instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | The Effect of Prenatal and Postnatal Treatment with Intravenous Immunoglobulin on Severity of Neonatal Hemochromatosis: The Tale of Two Brothers (Case Report).
Background Neonatal hemochromatosis (NH) is a rare condition that was the main reason for liver transplantation in infants. With the realization that NH result... | HUMAN IMMUNOGLOBULIN G | DrugsGivenReaction | CC BY-NC-ND | 34221693 | 19,580,210 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Serum ferritin increased'. | The Effect of Prenatal and Postnatal Treatment with Intravenous Immunoglobulin on Severity of Neonatal Hemochromatosis: The Tale of Two Brothers (Case Report).
Background Neonatal hemochromatosis (NH) is a rare condition that was the main reason for liver transplantation in infants. With the realization that NH result... | HUMAN IMMUNOGLOBULIN G | DrugsGivenReaction | CC BY-NC-ND | 34221693 | 19,580,210 | 2021-04 |
What is the weight of the patient? | The Effect of Prenatal and Postnatal Treatment with Intravenous Immunoglobulin on Severity of Neonatal Hemochromatosis: The Tale of Two Brothers (Case Report).
Background Neonatal hemochromatosis (NH) is a rare condition that was the main reason for liver transplantation in infants. With the realization that NH result... | 3.28 kg. | Weight | CC BY-NC-ND | 34221693 | 19,580,210 | 2021-04 |
What was the administration route of drug 'DEXTROSE'? | The Effect of Prenatal and Postnatal Treatment with Intravenous Immunoglobulin on Severity of Neonatal Hemochromatosis: The Tale of Two Brothers (Case Report).
Background Neonatal hemochromatosis (NH) is a rare condition that was the main reason for liver transplantation in infants. With the realization that NH result... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34221693 | 20,041,955 | 2021-04 |
What was the dosage of drug 'HUMAN IMMUNOGLOBULIN G'? | The Effect of Prenatal and Postnatal Treatment with Intravenous Immunoglobulin on Severity of Neonatal Hemochromatosis: The Tale of Two Brothers (Case Report).
Background Neonatal hemochromatosis (NH) is a rare condition that was the main reason for liver transplantation in infants. With the realization that NH result... | 1 GRAM PER KILOGRAM | DrugDosageText | CC BY-NC-ND | 34221693 | 19,580,210 | 2021-04 |
What was the outcome of reaction 'Blood fibrinogen decreased'? | The Effect of Prenatal and Postnatal Treatment with Intravenous Immunoglobulin on Severity of Neonatal Hemochromatosis: The Tale of Two Brothers (Case Report).
Background Neonatal hemochromatosis (NH) is a rare condition that was the main reason for liver transplantation in infants. With the realization that NH result... | Recovered | ReactionOutcome | CC BY-NC-ND | 34221693 | 19,580,210 | 2021-04 |
What was the outcome of reaction 'Foetal exposure during pregnancy'? | The Effect of Prenatal and Postnatal Treatment with Intravenous Immunoglobulin on Severity of Neonatal Hemochromatosis: The Tale of Two Brothers (Case Report).
Background Neonatal hemochromatosis (NH) is a rare condition that was the main reason for liver transplantation in infants. With the realization that NH result... | Recovered | ReactionOutcome | CC BY-NC-ND | 34221693 | 19,580,210 | 2021-04 |
What was the outcome of reaction 'Hepatic function abnormal'? | The Effect of Prenatal and Postnatal Treatment with Intravenous Immunoglobulin on Severity of Neonatal Hemochromatosis: The Tale of Two Brothers (Case Report).
Background Neonatal hemochromatosis (NH) is a rare condition that was the main reason for liver transplantation in infants. With the realization that NH result... | Recovered | ReactionOutcome | CC BY-NC-ND | 34221693 | 19,580,210 | 2021-04 |
What was the outcome of reaction 'Hypoglycaemia neonatal'? | The Effect of Prenatal and Postnatal Treatment with Intravenous Immunoglobulin on Severity of Neonatal Hemochromatosis: The Tale of Two Brothers (Case Report).
Background Neonatal hemochromatosis (NH) is a rare condition that was the main reason for liver transplantation in infants. With the realization that NH result... | Recovered | ReactionOutcome | CC BY-NC-ND | 34221693 | 19,580,210 | 2021-04 |
What was the outcome of reaction 'International normalised ratio increased'? | The Effect of Prenatal and Postnatal Treatment with Intravenous Immunoglobulin on Severity of Neonatal Hemochromatosis: The Tale of Two Brothers (Case Report).
Background Neonatal hemochromatosis (NH) is a rare condition that was the main reason for liver transplantation in infants. With the realization that NH result... | Recovered | ReactionOutcome | CC BY-NC-ND | 34221693 | 19,580,210 | 2021-04 |
What was the outcome of reaction 'Neonatal haemochromatosis'? | The Effect of Prenatal and Postnatal Treatment with Intravenous Immunoglobulin on Severity of Neonatal Hemochromatosis: The Tale of Two Brothers (Case Report).
Background Neonatal hemochromatosis (NH) is a rare condition that was the main reason for liver transplantation in infants. With the realization that NH result... | Recovered | ReactionOutcome | CC BY-NC-ND | 34221693 | 19,580,210 | 2021-04 |
What was the outcome of reaction 'Serum ferritin increased'? | The Effect of Prenatal and Postnatal Treatment with Intravenous Immunoglobulin on Severity of Neonatal Hemochromatosis: The Tale of Two Brothers (Case Report).
Background Neonatal hemochromatosis (NH) is a rare condition that was the main reason for liver transplantation in infants. With the realization that NH result... | Recovered | ReactionOutcome | CC BY-NC-ND | 34221693 | 19,580,210 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bladder cancer recurrent'. | Safety of adjuvant gemcitabine plus cisplatin chemotherapy in a patient with bilateral ureteral cancer undergoing hemodialysis.
An 80 year old Japanese man with bilateral ureteral cancer underwent laparoscopic bilateral nephroureterectomy and lymph-node dissection. The pathological stage of the left and right ureteral ... | CISPLATIN, GEMCITABINE | DrugsGivenReaction | CC BY | 34221834 | 17,375,593 | 2021-07 |
What was the administration route of drug 'CISPLATIN'? | Safety of adjuvant gemcitabine plus cisplatin chemotherapy in a patient with bilateral ureteral cancer undergoing hemodialysis.
An 80 year old Japanese man with bilateral ureteral cancer underwent laparoscopic bilateral nephroureterectomy and lymph-node dissection. The pathological stage of the left and right ureteral ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34221834 | 19,471,672 | 2021-07 |
What was the administration route of drug 'GEMCITABINE'? | Safety of adjuvant gemcitabine plus cisplatin chemotherapy in a patient with bilateral ureteral cancer undergoing hemodialysis.
An 80 year old Japanese man with bilateral ureteral cancer underwent laparoscopic bilateral nephroureterectomy and lymph-node dissection. The pathological stage of the left and right ureteral ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34221834 | 17,375,593 | 2021-07 |
What was the administration route of drug 'GEMCITABINE\GEMCITABINE HYDROCHLORIDE'? | Safety of adjuvant gemcitabine plus cisplatin chemotherapy in a patient with bilateral ureteral cancer undergoing hemodialysis.
An 80 year old Japanese man with bilateral ureteral cancer underwent laparoscopic bilateral nephroureterectomy and lymph-node dissection. The pathological stage of the left and right ureteral ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34221834 | 19,471,672 | 2021-07 |
What was the administration route of drug 'SODIUM CHLORIDE'? | Safety of adjuvant gemcitabine plus cisplatin chemotherapy in a patient with bilateral ureteral cancer undergoing hemodialysis.
An 80 year old Japanese man with bilateral ureteral cancer underwent laparoscopic bilateral nephroureterectomy and lymph-node dissection. The pathological stage of the left and right ureteral ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34221834 | 19,471,672 | 2021-07 |
What was the dosage of drug 'GEMCITABINE\GEMCITABINE HYDROCHLORIDE'? | Safety of adjuvant gemcitabine plus cisplatin chemotherapy in a patient with bilateral ureteral cancer undergoing hemodialysis.
An 80 year old Japanese man with bilateral ureteral cancer underwent laparoscopic bilateral nephroureterectomy and lymph-node dissection. The pathological stage of the left and right ureteral ... | ON DAY 1, ON DAY 8?1000 MG/M2 OF GEM DISSOLVED IN 100 ML OF SALINE INTRAVENOUSLY OVER 30 MIN | DrugDosageText | CC BY | 34221834 | 19,471,672 | 2021-07 |
What was the outcome of reaction 'Leukopenia'? | Safety of adjuvant gemcitabine plus cisplatin chemotherapy in a patient with bilateral ureteral cancer undergoing hemodialysis.
An 80 year old Japanese man with bilateral ureteral cancer underwent laparoscopic bilateral nephroureterectomy and lymph-node dissection. The pathological stage of the left and right ureteral ... | Recovering | ReactionOutcome | CC BY | 34221834 | 17,359,372 | 2021-07 |
What was the outcome of reaction 'Neutropenia'? | Safety of adjuvant gemcitabine plus cisplatin chemotherapy in a patient with bilateral ureteral cancer undergoing hemodialysis.
An 80 year old Japanese man with bilateral ureteral cancer underwent laparoscopic bilateral nephroureterectomy and lymph-node dissection. The pathological stage of the left and right ureteral ... | Recovering | ReactionOutcome | CC BY | 34221834 | 17,359,372 | 2021-07 |
What was the outcome of reaction 'Thrombocytopenia'? | Safety of adjuvant gemcitabine plus cisplatin chemotherapy in a patient with bilateral ureteral cancer undergoing hemodialysis.
An 80 year old Japanese man with bilateral ureteral cancer underwent laparoscopic bilateral nephroureterectomy and lymph-node dissection. The pathological stage of the left and right ureteral ... | Recovering | ReactionOutcome | CC BY | 34221834 | 17,359,372 | 2021-07 |
What was the administration route of drug 'TOCILIZUMAB'? | COVID-19-Related Pericarditis with Pericardial Clotting as a Hallmark: Two Cases and a Review.
The prevalence of pericardial effusion and its clinical significance is not well understood in COVID-19 patients. We report two cases of COVID-19-related pericardial effusion complicated by intrapericardial clot formation. Th... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-SA | 34221878 | 20,167,841 | 2021 |
What was the dosage of drug 'EDOXABAN'? | COVID-19-Related Pericarditis with Pericardial Clotting as a Hallmark: Two Cases and a Review.
The prevalence of pericardial effusion and its clinical significance is not well understood in COVID-19 patients. We report two cases of COVID-19-related pericardial effusion complicated by intrapericardial clot formation. Th... | 30 MILLIGRAM, QD | DrugDosageText | CC BY-NC-SA | 34221878 | 20,167,841 | 2021 |
What was the dosage of drug 'ENOXAPARIN'? | COVID-19-Related Pericarditis with Pericardial Clotting as a Hallmark: Two Cases and a Review.
The prevalence of pericardial effusion and its clinical significance is not well understood in COVID-19 patients. We report two cases of COVID-19-related pericardial effusion complicated by intrapericardial clot formation. Th... | 1 MILLIGRAM/KILOGRAM, BID | DrugDosageText | CC BY-NC-SA | 34221878 | 20,162,952 | 2021 |
What was the dosage of drug 'HYDROXYCHLOROQUINE'? | COVID-19-Related Pericarditis with Pericardial Clotting as a Hallmark: Two Cases and a Review.
The prevalence of pericardial effusion and its clinical significance is not well understood in COVID-19 patients. We report two cases of COVID-19-related pericardial effusion complicated by intrapericardial clot formation. Th... | 200 MILLIGRAM, BID | DrugDosageText | CC BY-NC-SA | 34221878 | 20,167,841 | 2021 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | COVID-19-Related Pericarditis with Pericardial Clotting as a Hallmark: Two Cases and a Review.
The prevalence of pericardial effusion and its clinical significance is not well understood in COVID-19 patients. We report two cases of COVID-19-related pericardial effusion complicated by intrapericardial clot formation. Th... | 1 MILLIGRAM/KILOGRAM, QD | DrugDosageText | CC BY-NC-SA | 34221878 | 20,162,952 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Conscious prone positioning in a pregnant patient with COVID-19 respiratory distress: A case report and review.
Prone positioning has been used for decades to improve oxygenation in patients with acute respiratory distress syndrome. With the COVID-19 pandemic there has been a growing emphasis on the utilization of pron... | BETAMETHASONE, HEPARIN SODIUM, REMDESIVIR | DrugsGivenReaction | CC BY-NC-ND | 34221902 | 20,730,977 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | Conscious prone positioning in a pregnant patient with COVID-19 respiratory distress: A case report and review.
Prone positioning has been used for decades to improve oxygenation in patients with acute respiratory distress syndrome. With the COVID-19 pandemic there has been a growing emphasis on the utilization of pron... | BETAMETHASONE ACETATE\BETAMETHASONE SODIUM PHOSPHATE, HEPARIN SODIUM, REMDESIVIR | DrugsGivenReaction | CC BY-NC-ND | 34221902 | 19,688,681 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Normal newborn'. | Conscious prone positioning in a pregnant patient with COVID-19 respiratory distress: A case report and review.
Prone positioning has been used for decades to improve oxygenation in patients with acute respiratory distress syndrome. With the COVID-19 pandemic there has been a growing emphasis on the utilization of pron... | BETAMETHASONE, HEPARIN SODIUM, REMDESIVIR | DrugsGivenReaction | CC BY-NC-ND | 34221902 | 20,730,977 | 2021-07 |
What was the dosage of drug 'BETAMETHASONE'? | Conscious prone positioning in a pregnant patient with COVID-19 respiratory distress: A case report and review.
Prone positioning has been used for decades to improve oxygenation in patients with acute respiratory distress syndrome. With the COVID-19 pandemic there has been a growing emphasis on the utilization of pron... | UNK (2 DAY COURSE) | DrugDosageText | CC BY-NC-ND | 34221902 | 20,730,977 | 2021-07 |
What was the dosage of drug 'REMDESIVIR'? | Conscious prone positioning in a pregnant patient with COVID-19 respiratory distress: A case report and review.
Prone positioning has been used for decades to improve oxygenation in patients with acute respiratory distress syndrome. With the COVID-19 pandemic there has been a growing emphasis on the utilization of pron... | UNK (5 DAY COURSE) | DrugDosageText | CC BY-NC-ND | 34221902 | 20,730,977 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | A PD-1 Inhibitor Induces Complete Response of Advanced Bladder Urothelial Carcinoma: A Case Report.
The prognosis of patients with advanced urothelial carcinoma is dismal. Platinum-based chemotherapy is still the main first-line treatment for advanced urothelial carcinoma, while immunotherapy can be used as a first-lin... | GEMCITABINE | DrugsGivenReaction | CC BY | 34221988 | 20,903,529 | 2021 |
What was the dosage of drug 'GEMCITABINE'? | A PD-1 Inhibitor Induces Complete Response of Advanced Bladder Urothelial Carcinoma: A Case Report.
The prognosis of patients with advanced urothelial carcinoma is dismal. Platinum-based chemotherapy is still the main first-line treatment for advanced urothelial carcinoma, while immunotherapy can be used as a first-lin... | UNK (1000 MG/M2, D1-8, Q21D) | DrugDosageText | CC BY | 34221988 | 20,903,529 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Case Report: Nintedanib for Pembrolizumab-Related Pneumonitis in a Patient With Non-Small Cell Lung Cancer.
Pembrolizumab, an immune checkpoint inhibitor (ICI) approved for advanced non-small cell lung cancer (NSCLC) treatment, has shown superior survival benefits. However, pembrolizumab may lead to severe immune-relat... | BEVACIZUMAB, METHYLPREDNISOLONE, NINTEDANIB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34221992 | 19,569,756 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastatic neoplasm'. | Case Report: Nintedanib for Pembrolizumab-Related Pneumonitis in a Patient With Non-Small Cell Lung Cancer.
Pembrolizumab, an immune checkpoint inhibitor (ICI) approved for advanced non-small cell lung cancer (NSCLC) treatment, has shown superior survival benefits. However, pembrolizumab may lead to severe immune-relat... | BEVACIZUMAB, METHYLPREDNISOLONE, NINTEDANIB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34221992 | 19,569,756 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Case Report: Nintedanib for Pembrolizumab-Related Pneumonitis in a Patient With Non-Small Cell Lung Cancer.
Pembrolizumab, an immune checkpoint inhibitor (ICI) approved for advanced non-small cell lung cancer (NSCLC) treatment, has shown superior survival benefits. However, pembrolizumab may lead to severe immune-relat... | BEVACIZUMAB, METHYLPREDNISOLONE, NINTEDANIB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34221992 | 19,569,756 | 2021 |
What was the dosage of drug 'PEMBROLIZUMAB'? | Case Report: Nintedanib for Pembrolizumab-Related Pneumonitis in a Patient With Non-Small Cell Lung Cancer.
Pembrolizumab, an immune checkpoint inhibitor (ICI) approved for advanced non-small cell lung cancer (NSCLC) treatment, has shown superior survival benefits. However, pembrolizumab may lead to severe immune-relat... | 100 MG OF PEMBROLIZUMAB. FORM OF ADMIN: INFUSION | DrugDosageText | CC BY | 34221992 | 19,569,756 | 2021 |
What was the outcome of reaction 'Death'? | Case Report: Nintedanib for Pembrolizumab-Related Pneumonitis in a Patient With Non-Small Cell Lung Cancer.
Pembrolizumab, an immune checkpoint inhibitor (ICI) approved for advanced non-small cell lung cancer (NSCLC) treatment, has shown superior survival benefits. However, pembrolizumab may lead to severe immune-relat... | Fatal | ReactionOutcome | CC BY | 34221992 | 19,569,756 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Alanine aminotransferase increased'. | Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure.
The prognosis for patients with relapsed or refractory diffuse large B-cell lymphoma (R/R-DLBCL) after se... | CISPLATIN, CYTARABINE, DECITABINE, DEXAMETHASONE, RITUXIMAB | DrugsGivenReaction | CC BY | 34222013 | 19,857,479 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure.
The prognosis for patients with relapsed or refractory diffuse large B-cell lymphoma (R/R-DLBCL) after se... | CISPLATIN, CYTARABINE, DECITABINE, DEXAMETHASONE, RITUXIMAB | DrugsGivenReaction | CC BY | 34222013 | 19,857,479 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aspartate aminotransferase increased'. | Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure.
The prognosis for patients with relapsed or refractory diffuse large B-cell lymphoma (R/R-DLBCL) after se... | CISPLATIN, CYTARABINE, DECITABINE, DEXAMETHASONE, RITUXIMAB | DrugsGivenReaction | CC BY | 34222013 | 19,857,479 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal haemorrhage'. | Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure.
The prognosis for patients with relapsed or refractory diffuse large B-cell lymphoma (R/R-DLBCL) after se... | CISPLATIN, CYTARABINE, DECITABINE, DEXAMETHASONE, RITUXIMAB | DrugsGivenReaction | CC BY | 34222013 | 19,857,479 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperbilirubinaemia'. | Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure.
The prognosis for patients with relapsed or refractory diffuse large B-cell lymphoma (R/R-DLBCL) after se... | CISPLATIN, CYTARABINE, DECITABINE, DEXAMETHASONE, RITUXIMAB | DrugsGivenReaction | CC BY | 34222013 | 19,857,479 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure.
The prognosis for patients with relapsed or refractory diffuse large B-cell lymphoma (R/R-DLBCL) after se... | CISPLATIN, CYTARABINE, DECITABINE, DEXAMETHASONE, RITUXIMAB | DrugsGivenReaction | CC BY | 34222013 | 19,857,479 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myelosuppression'. | Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure.
The prognosis for patients with relapsed or refractory diffuse large B-cell lymphoma (R/R-DLBCL) after se... | CISPLATIN, CYTARABINE, DECITABINE, DEXAMETHASONE, RITUXIMAB | DrugsGivenReaction | CC BY | 34222013 | 19,857,479 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure.
The prognosis for patients with relapsed or refractory diffuse large B-cell lymphoma (R/R-DLBCL) after se... | CISPLATIN, CYTARABINE, DECITABINE, DEXAMETHASONE, RITUXIMAB | DrugsGivenReaction | CC BY | 34222013 | 19,857,479 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ototoxicity'. | Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure.
The prognosis for patients with relapsed or refractory diffuse large B-cell lymphoma (R/R-DLBCL) after se... | CISPLATIN, CYTARABINE, DECITABINE, DEXAMETHASONE, RITUXIMAB | DrugsGivenReaction | CC BY | 34222013 | 19,857,479 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure.
The prognosis for patients with relapsed or refractory diffuse large B-cell lymphoma (R/R-DLBCL) after se... | CISPLATIN, CYTARABINE, DECITABINE, DEXAMETHASONE, RITUXIMAB | DrugsGivenReaction | CC BY | 34222013 | 19,857,479 | 2021 |
What was the administration route of drug 'CISPLATIN'? | Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure.
The prognosis for patients with relapsed or refractory diffuse large B-cell lymphoma (R/R-DLBCL) after se... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34222013 | 19,857,479 | 2021 |
What was the administration route of drug 'CYTARABINE'? | Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure.
The prognosis for patients with relapsed or refractory diffuse large B-cell lymphoma (R/R-DLBCL) after se... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34222013 | 19,857,479 | 2021 |
What was the administration route of drug 'RITUXIMAB'? | Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure.
The prognosis for patients with relapsed or refractory diffuse large B-cell lymphoma (R/R-DLBCL) after se... | Intravenous drip | DrugAdministrationRoute | CC BY | 34222013 | 19,857,479 | 2021 |
What was the dosage of drug 'CYTARABINE'? | Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure.
The prognosis for patients with relapsed or refractory diffuse large B-cell lymphoma (R/R-DLBCL) after se... | 2 G/M2 | DrugDosageText | CC BY | 34222013 | 19,857,479 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Asthenia'. | Lurbinectedin in Refractory Diffuse Malignant Peritoneal Mesothelioma: Report of Two Cases.
Mesothelioma is a malignancy of serosal membranes. Parietal pleura is the most common site, with peritoneum being the second most frequent location. Malignant peritoneal mesothelioma (MPM) is a rare and aggressive disease. The p... | CISPLATIN, GEMCITABINE, IPILIMUMAB, NIVOLUMAB, PEMBROLIZUMAB, PEMETREXED, VINORELBINE TARTRATE | DrugsGivenReaction | CC BY | 34222029 | 19,953,998 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Decreased appetite'. | Lurbinectedin in Refractory Diffuse Malignant Peritoneal Mesothelioma: Report of Two Cases.
Mesothelioma is a malignancy of serosal membranes. Parietal pleura is the most common site, with peritoneum being the second most frequent location. Malignant peritoneal mesothelioma (MPM) is a rare and aggressive disease. The p... | CISPLATIN, GEMCITABINE, IPILIMUMAB, NIVOLUMAB, PEMBROLIZUMAB, PEMETREXED, VINORELBINE TARTRATE | DrugsGivenReaction | CC BY | 34222029 | 19,953,998 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Lurbinectedin in Refractory Diffuse Malignant Peritoneal Mesothelioma: Report of Two Cases.
Mesothelioma is a malignancy of serosal membranes. Parietal pleura is the most common site, with peritoneum being the second most frequent location. Malignant peritoneal mesothelioma (MPM) is a rare and aggressive disease. The p... | CARBOPLATIN, GEMCITABINE, NIVOLUMAB, PEMETREXED, VINORELBINE TARTRATE | DrugsGivenReaction | CC BY | 34222029 | 19,954,059 | 2021 |
What was the dosage of drug 'CARBOPLATIN'? | Lurbinectedin in Refractory Diffuse Malignant Peritoneal Mesothelioma: Report of Two Cases.
Mesothelioma is a malignancy of serosal membranes. Parietal pleura is the most common site, with peritoneum being the second most frequent location. Malignant peritoneal mesothelioma (MPM) is a rare and aggressive disease. The p... | UNK, 6 CYCLES | DrugDosageText | CC BY | 34222029 | 19,954,059 | 2021 |
What was the dosage of drug 'GEMCITABINE'? | Lurbinectedin in Refractory Diffuse Malignant Peritoneal Mesothelioma: Report of Two Cases.
Mesothelioma is a malignancy of serosal membranes. Parietal pleura is the most common site, with peritoneum being the second most frequent location. Malignant peritoneal mesothelioma (MPM) is a rare and aggressive disease. The p... | UNK, 8 CYCLES | DrugDosageText | CC BY | 34222029 | 19,954,059 | 2021 |
What was the dosage of drug 'NIVOLUMAB'? | Lurbinectedin in Refractory Diffuse Malignant Peritoneal Mesothelioma: Report of Two Cases.
Mesothelioma is a malignancy of serosal membranes. Parietal pleura is the most common site, with peritoneum being the second most frequent location. Malignant peritoneal mesothelioma (MPM) is a rare and aggressive disease. The p... | UNK, 5 CYCLES | DrugDosageText | CC BY | 34222029 | 19,954,059 | 2021 |
What was the dosage of drug 'PEMETREXED'? | Lurbinectedin in Refractory Diffuse Malignant Peritoneal Mesothelioma: Report of Two Cases.
Mesothelioma is a malignancy of serosal membranes. Parietal pleura is the most common site, with peritoneum being the second most frequent location. Malignant peritoneal mesothelioma (MPM) is a rare and aggressive disease. The p... | UNK, 6 CYCLES | DrugDosageText | CC BY | 34222029 | 19,954,059 | 2021 |
What was the dosage of drug 'VINORELBINE TARTRATE'? | Lurbinectedin in Refractory Diffuse Malignant Peritoneal Mesothelioma: Report of Two Cases.
Mesothelioma is a malignancy of serosal membranes. Parietal pleura is the most common site, with peritoneum being the second most frequent location. Malignant peritoneal mesothelioma (MPM) is a rare and aggressive disease. The p... | UNK, 8 CYCLES | DrugDosageText | CC BY | 34222029 | 19,954,059 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | A rare case of shingles after COVID-19 vaccine: is it a possible adverse effect?
Coronavirus disease 2019 (COVID-19) exhibit mild to moderate symptoms, whereas 15% of COVID-19 cases progress to pneumonia, some associated cutaneous findings are also reported as maculopapular eruptions, morbilliform rashes, urticaria, ch... | ACETAMINOPHEN, ACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34222134 | 20,159,020 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pruritus'. | A rare case of shingles after COVID-19 vaccine: is it a possible adverse effect?
Coronavirus disease 2019 (COVID-19) exhibit mild to moderate symptoms, whereas 15% of COVID-19 cases progress to pneumonia, some associated cutaneous findings are also reported as maculopapular eruptions, morbilliform rashes, urticaria, ch... | ACETAMINOPHEN, ACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34222134 | 20,159,020 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Scab'. | A rare case of shingles after COVID-19 vaccine: is it a possible adverse effect?
Coronavirus disease 2019 (COVID-19) exhibit mild to moderate symptoms, whereas 15% of COVID-19 cases progress to pneumonia, some associated cutaneous findings are also reported as maculopapular eruptions, morbilliform rashes, urticaria, ch... | ACETAMINOPHEN, ACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34222134 | 20,159,020 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Immune Thrombocytopenia Revealing Enriched IgG-4 Peri-Renal Rosai-Dorfman Disease Successfully Treated with Rituximab: A Case Report and Literature Review.
Immune thrombocytopenia (ITP) is a rare autoimmune-mediated condition characterized by isolated thrombocytopenia (<100 G/L) after exclusion of other causes. Mostly ... | HUMAN IMMUNOGLOBULIN G, PREDNISONE, RITUXIMAB | DrugsGivenReaction | CC BY | 34222286 | 20,141,785 | 2021 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | Immune Thrombocytopenia Revealing Enriched IgG-4 Peri-Renal Rosai-Dorfman Disease Successfully Treated with Rituximab: A Case Report and Literature Review.
Immune thrombocytopenia (ITP) is a rare autoimmune-mediated condition characterized by isolated thrombocytopenia (<100 G/L) after exclusion of other causes. Mostly ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34222286 | 20,141,785 | 2021 |
What was the dosage of drug 'PREDNISONE'? | Immune Thrombocytopenia Revealing Enriched IgG-4 Peri-Renal Rosai-Dorfman Disease Successfully Treated with Rituximab: A Case Report and Literature Review.
Immune thrombocytopenia (ITP) is a rare autoimmune-mediated condition characterized by isolated thrombocytopenia (<100 G/L) after exclusion of other causes. Mostly ... | 1 MILLIGRAM PER KILOGRAM | DrugDosageText | CC BY | 34222286 | 20,141,785 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neoplasm progression'. | Long-term response to avelumab and management of oligoprogression in Merkel cell carcinoma: A case report.
Merkel cell carcinoma (MCC) is a rare and aggressive cutaneous neuroendocrine neoplasia, with high risk of recurrence and metastasis and poor survival. Immune checkpoint inhibitors, like the anti-programmed death-... | AVELUMAB | DrugsGivenReaction | CC BY-NC | 34222455 | 19,829,371 | 2021-06-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Long-term response to avelumab and management of oligoprogression in Merkel cell carcinoma: A case report.
Merkel cell carcinoma (MCC) is a rare and aggressive cutaneous neuroendocrine neoplasia, with high risk of recurrence and metastasis and poor survival. Immune checkpoint inhibitors, like the anti-programmed death-... | AVELUMAB, CISPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC | 34222455 | 19,692,443 | 2021-06-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Long-term response to avelumab and management of oligoprogression in Merkel cell carcinoma: A case report.
Merkel cell carcinoma (MCC) is a rare and aggressive cutaneous neuroendocrine neoplasia, with high risk of recurrence and metastasis and poor survival. Immune checkpoint inhibitors, like the anti-programmed death-... | AVELUMAB, CISPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC | 34222455 | 19,692,443 | 2021-06-26 |
What was the dosage of drug 'CISPLATIN'? | Long-term response to avelumab and management of oligoprogression in Merkel cell carcinoma: A case report.
Merkel cell carcinoma (MCC) is a rare and aggressive cutaneous neuroendocrine neoplasia, with high risk of recurrence and metastasis and poor survival. Immune checkpoint inhibitors, like the anti-programmed death-... | ON DAY 1 IN 3?WEEK CYCLE | DrugDosageText | CC BY-NC | 34222455 | 19,692,443 | 2021-06-26 |
What was the dosage of drug 'ETOPOSIDE'? | Long-term response to avelumab and management of oligoprogression in Merkel cell carcinoma: A case report.
Merkel cell carcinoma (MCC) is a rare and aggressive cutaneous neuroendocrine neoplasia, with high risk of recurrence and metastasis and poor survival. Immune checkpoint inhibitors, like the anti-programmed death-... | ON DAY 1?3 IN A 3?WEEK CYCLE | DrugDosageText | CC BY-NC | 34222455 | 19,692,443 | 2021-06-26 |
What was the outcome of reaction 'Neoplasm progression'? | Long-term response to avelumab and management of oligoprogression in Merkel cell carcinoma: A case report.
Merkel cell carcinoma (MCC) is a rare and aggressive cutaneous neuroendocrine neoplasia, with high risk of recurrence and metastasis and poor survival. Immune checkpoint inhibitors, like the anti-programmed death-... | Recovered | ReactionOutcome | CC BY-NC | 34222455 | 19,829,371 | 2021-06-26 |
What was the outcome of reaction 'Neutropenia'? | Long-term response to avelumab and management of oligoprogression in Merkel cell carcinoma: A case report.
Merkel cell carcinoma (MCC) is a rare and aggressive cutaneous neuroendocrine neoplasia, with high risk of recurrence and metastasis and poor survival. Immune checkpoint inhibitors, like the anti-programmed death-... | Recovering | ReactionOutcome | CC BY-NC | 34222455 | 19,692,443 | 2021-06-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'COVID-19'. | Low symptomatic COVID-19 in an elderly patient with follicular lymphoma treated with rituximab-based immunotherapy: A case report.
BACKGROUND
Follicular lymphoma is an indolent lymphoma that may progress to a highly aggressive form requiring immunochemotherapy. Most regimens utilize rituximab, an anti-CD20 monoclonal a... | CYCLOPHOSPHAMIDE, PREDNISONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY-NC | 34222459 | 19,812,267 | 2021-06-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Decreased appetite'. | Low symptomatic COVID-19 in an elderly patient with follicular lymphoma treated with rituximab-based immunotherapy: A case report.
BACKGROUND
Follicular lymphoma is an indolent lymphoma that may progress to a highly aggressive form requiring immunochemotherapy. Most regimens utilize rituximab, an anti-CD20 monoclonal a... | CYCLOPHOSPHAMIDE, PREDNISONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY-NC | 34222459 | 19,595,398 | 2021-06-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Low symptomatic COVID-19 in an elderly patient with follicular lymphoma treated with rituximab-based immunotherapy: A case report.
BACKGROUND
Follicular lymphoma is an indolent lymphoma that may progress to a highly aggressive form requiring immunochemotherapy. Most regimens utilize rituximab, an anti-CD20 monoclonal a... | CYCLOPHOSPHAMIDE, PREDNISONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY-NC | 34222459 | 19,595,398 | 2021-06-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Low symptomatic COVID-19 in an elderly patient with follicular lymphoma treated with rituximab-based immunotherapy: A case report.
BACKGROUND
Follicular lymphoma is an indolent lymphoma that may progress to a highly aggressive form requiring immunochemotherapy. Most regimens utilize rituximab, an anti-CD20 monoclonal a... | CYCLOPHOSPHAMIDE, PREDNISONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY-NC | 34222459 | 19,595,398 | 2021-06-26 |
What was the outcome of reaction 'COVID-19'? | Low symptomatic COVID-19 in an elderly patient with follicular lymphoma treated with rituximab-based immunotherapy: A case report.
BACKGROUND
Follicular lymphoma is an indolent lymphoma that may progress to a highly aggressive form requiring immunochemotherapy. Most regimens utilize rituximab, an anti-CD20 monoclonal a... | Recovered | ReactionOutcome | CC BY-NC | 34222459 | 19,812,267 | 2021-06-26 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Coronary artery aneurysm'. | Importance of blood pressure control in Kawasaki disease with expanded multiple giant coronary aneurysms with a 32 mm maximum diameter: a case report.
Ruptured coronary artery aneurysm is rare, but the most serious complications of an acute phase of Kawasaki disease (KD) with giant coronary artery aneurysm (GCAA). Prog... | HUMAN IMMUNOGLOBULIN G, METHYLPREDNISOLONE SODIUM SUCCINATE, PREDNISOLONE, WARFARIN | DrugsGivenReaction | CC BY-NC | 34222780 | 19,736,852 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypertension'. | Importance of blood pressure control in Kawasaki disease with expanded multiple giant coronary aneurysms with a 32 mm maximum diameter: a case report.
Ruptured coronary artery aneurysm is rare, but the most serious complications of an acute phase of Kawasaki disease (KD) with giant coronary artery aneurysm (GCAA). Prog... | HUMAN IMMUNOGLOBULIN G, METHYLPREDNISOLONE SODIUM SUCCINATE, PREDNISOLONE, WARFARIN | DrugsGivenReaction | CC BY-NC | 34222780 | 19,736,852 | 2021-06 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | Importance of blood pressure control in Kawasaki disease with expanded multiple giant coronary aneurysms with a 32 mm maximum diameter: a case report.
Ruptured coronary artery aneurysm is rare, but the most serious complications of an acute phase of Kawasaki disease (KD) with giant coronary artery aneurysm (GCAA). Prog... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34222780 | 19,736,852 | 2021-06 |
What was the administration route of drug 'METHYLPREDNISOLONE SODIUM SUCCINATE'? | Importance of blood pressure control in Kawasaki disease with expanded multiple giant coronary aneurysms with a 32 mm maximum diameter: a case report.
Ruptured coronary artery aneurysm is rare, but the most serious complications of an acute phase of Kawasaki disease (KD) with giant coronary artery aneurysm (GCAA). Prog... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34222780 | 19,736,852 | 2021-06 |
What was the administration route of drug 'PREDNISOLONE'? | Importance of blood pressure control in Kawasaki disease with expanded multiple giant coronary aneurysms with a 32 mm maximum diameter: a case report.
Ruptured coronary artery aneurysm is rare, but the most serious complications of an acute phase of Kawasaki disease (KD) with giant coronary artery aneurysm (GCAA). Prog... | Oral | DrugAdministrationRoute | CC BY-NC | 34222780 | 19,736,852 | 2021-06 |
What was the administration route of drug 'WARFARIN'? | Importance of blood pressure control in Kawasaki disease with expanded multiple giant coronary aneurysms with a 32 mm maximum diameter: a case report.
Ruptured coronary artery aneurysm is rare, but the most serious complications of an acute phase of Kawasaki disease (KD) with giant coronary artery aneurysm (GCAA). Prog... | Oral | DrugAdministrationRoute | CC BY-NC | 34222780 | 19,736,852 | 2021-06 |
What was the dosage of drug 'HUMAN IMMUNOGLOBULIN G'? | Importance of blood pressure control in Kawasaki disease with expanded multiple giant coronary aneurysms with a 32 mm maximum diameter: a case report.
Ruptured coronary artery aneurysm is rare, but the most serious complications of an acute phase of Kawasaki disease (KD) with giant coronary artery aneurysm (GCAA). Prog... | IVIG; 4 G/KG TOTAL | DrugDosageText | CC BY-NC | 34222780 | 19,736,852 | 2021-06 |
What was the dosage of drug 'METHYLPREDNISOLONE SODIUM SUCCINATE'? | Importance of blood pressure control in Kawasaki disease with expanded multiple giant coronary aneurysms with a 32 mm maximum diameter: a case report.
Ruptured coronary artery aneurysm is rare, but the most serious complications of an acute phase of Kawasaki disease (KD) with giant coronary artery aneurysm (GCAA). Prog... | 30 MG/KG | DrugDosageText | CC BY-NC | 34222780 | 19,736,852 | 2021-06 |
What was the outcome of reaction 'Coronary artery aneurysm'? | Importance of blood pressure control in Kawasaki disease with expanded multiple giant coronary aneurysms with a 32 mm maximum diameter: a case report.
Ruptured coronary artery aneurysm is rare, but the most serious complications of an acute phase of Kawasaki disease (KD) with giant coronary artery aneurysm (GCAA). Prog... | Recovering | ReactionOutcome | CC BY-NC | 34222780 | 19,736,852 | 2021-06 |
What was the outcome of reaction 'Hypertension'? | Importance of blood pressure control in Kawasaki disease with expanded multiple giant coronary aneurysms with a 32 mm maximum diameter: a case report.
Ruptured coronary artery aneurysm is rare, but the most serious complications of an acute phase of Kawasaki disease (KD) with giant coronary artery aneurysm (GCAA). Prog... | Recovering | ReactionOutcome | CC BY-NC | 34222780 | 19,736,852 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dyspnoea'. | Acquired pulmonary vein stenosis resulting in haemoptysis: a case series.
Acquired pulmonary vein stenosis (PVS) is an infrequent complication of atrial fibrillation ablation that is often misdiagnosed due to predominant respiratory symptoms. It can result in pulmonary venous hypertension, with varying presentations, r... | RIVAROXABAN | DrugsGivenReaction | CC BY-NC | 34222784 | 19,679,189 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary vein stenosis'. | Acquired pulmonary vein stenosis resulting in haemoptysis: a case series.
Acquired pulmonary vein stenosis (PVS) is an infrequent complication of atrial fibrillation ablation that is often misdiagnosed due to predominant respiratory symptoms. It can result in pulmonary venous hypertension, with varying presentations, r... | RIVAROXABAN | DrugsGivenReaction | CC BY-NC | 34222784 | 19,679,189 | 2021-06 |
What was the administration route of drug 'RIVAROXABAN'? | Acquired pulmonary vein stenosis resulting in haemoptysis: a case series.
Acquired pulmonary vein stenosis (PVS) is an infrequent complication of atrial fibrillation ablation that is often misdiagnosed due to predominant respiratory symptoms. It can result in pulmonary venous hypertension, with varying presentations, r... | Oral | DrugAdministrationRoute | CC BY-NC | 34222784 | 19,679,189 | 2021-06 |
What was the outcome of reaction 'Dyspnoea'? | Acquired pulmonary vein stenosis resulting in haemoptysis: a case series.
Acquired pulmonary vein stenosis (PVS) is an infrequent complication of atrial fibrillation ablation that is often misdiagnosed due to predominant respiratory symptoms. It can result in pulmonary venous hypertension, with varying presentations, r... | Recovered | ReactionOutcome | CC BY-NC | 34222784 | 19,679,189 | 2021-06 |
What was the outcome of reaction 'Haemoptysis'? | Acquired pulmonary vein stenosis resulting in haemoptysis: a case series.
Acquired pulmonary vein stenosis (PVS) is an infrequent complication of atrial fibrillation ablation that is often misdiagnosed due to predominant respiratory symptoms. It can result in pulmonary venous hypertension, with varying presentations, r... | Recovered | ReactionOutcome | CC BY-NC | 34222784 | 19,679,189 | 2021-06 |
What was the outcome of reaction 'Pulmonary vein stenosis'? | Acquired pulmonary vein stenosis resulting in haemoptysis: a case series.
Acquired pulmonary vein stenosis (PVS) is an infrequent complication of atrial fibrillation ablation that is often misdiagnosed due to predominant respiratory symptoms. It can result in pulmonary venous hypertension, with varying presentations, r... | Recovered | ReactionOutcome | CC BY-NC | 34222784 | 19,679,189 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal discomfort'. | Compassionate use of cefiderocol for carbapenem-resistant Acinetobacter baumannii prosthetic joint infection.
Cefiderocol is a recently licensed novel siderophore-conjugated cephalosporin stable to hydrolysis by serine and MBLs. It has been successfully used to treat Enterobacterales infections and is approved for the ... | COLISTIN, TIGECYCLINE | DrugsGivenReaction | CC BY | 34223152 | 19,581,896 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Compassionate use of cefiderocol for carbapenem-resistant Acinetobacter baumannii prosthetic joint infection.
Cefiderocol is a recently licensed novel siderophore-conjugated cephalosporin stable to hydrolysis by serine and MBLs. It has been successfully used to treat Enterobacterales infections and is approved for the ... | COLISTIN, TIGECYCLINE | DrugsGivenReaction | CC BY | 34223152 | 19,581,896 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dehydration'. | Compassionate use of cefiderocol for carbapenem-resistant Acinetobacter baumannii prosthetic joint infection.
Cefiderocol is a recently licensed novel siderophore-conjugated cephalosporin stable to hydrolysis by serine and MBLs. It has been successfully used to treat Enterobacterales infections and is approved for the ... | COLISTIN, TIGECYCLINE | DrugsGivenReaction | CC BY | 34223152 | 19,581,896 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Compassionate use of cefiderocol for carbapenem-resistant Acinetobacter baumannii prosthetic joint infection.
Cefiderocol is a recently licensed novel siderophore-conjugated cephalosporin stable to hydrolysis by serine and MBLs. It has been successfully used to treat Enterobacterales infections and is approved for the ... | COLISTIN, TIGECYCLINE | DrugsGivenReaction | CC BY | 34223152 | 19,581,896 | 2021-06 |
What was the administration route of drug 'COLISTIN'? | Compassionate use of cefiderocol for carbapenem-resistant Acinetobacter baumannii prosthetic joint infection.
Cefiderocol is a recently licensed novel siderophore-conjugated cephalosporin stable to hydrolysis by serine and MBLs. It has been successfully used to treat Enterobacterales infections and is approved for the ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34223152 | 19,581,896 | 2021-06 |
What was the dosage of drug 'COLISTIN'? | Compassionate use of cefiderocol for carbapenem-resistant Acinetobacter baumannii prosthetic joint infection.
Cefiderocol is a recently licensed novel siderophore-conjugated cephalosporin stable to hydrolysis by serine and MBLs. It has been successfully used to treat Enterobacterales infections and is approved for the ... | 9MU LOADING DOSE FOLLOWED BY 3MU 8 HOURLY | DrugDosageText | CC BY | 34223152 | 19,581,896 | 2021-06 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.